Healthcare Global Enterprises Ltd
NSE:HCG
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
315.2
474.65
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one HCG stock under the Base Case scenario is 492.71 INR. Compared to the current market price of 468.3 INR, Healthcare Global Enterprises Ltd is Undervalued by 5%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Healthcare Global Enterprises Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for HCG cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Healthcare Global Enterprises Ltd
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Healthcare Global Enterprises Ltd
Balance Sheet Decomposition
Healthcare Global Enterprises Ltd
Current Assets | 6.8B |
Cash & Short-Term Investments | 3.1B |
Receivables | 3B |
Other Current Assets | 740.3m |
Non-Current Assets | 20.3B |
Long-Term Investments | 589.5m |
PP&E | 15.9B |
Intangibles | 2.5B |
Other Non-Current Assets | 1.3B |
Current Liabilities | 7.4B |
Accounts Payable | 2.8B |
Other Current Liabilities | 4.6B |
Non-Current Liabilities | 11.4B |
Long-Term Debt | 10.4B |
Other Non-Current Liabilities | 939m |
Earnings Waterfall
Healthcare Global Enterprises Ltd
Revenue
|
19.7B
INR
|
Cost of Revenue
|
-9.2B
INR
|
Gross Profit
|
10.5B
INR
|
Operating Expenses
|
-8.9B
INR
|
Operating Income
|
1.6B
INR
|
Other Expenses
|
-1.1B
INR
|
Net Income
|
526.1m
INR
|
Free Cash Flow Analysis
Healthcare Global Enterprises Ltd
INR | |
Free Cash Flow | INR |
HCG Profitability Score
Profitability Due Diligence
Healthcare Global Enterprises Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
Score
Healthcare Global Enterprises Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
HCG Solvency Score
Solvency Due Diligence
Healthcare Global Enterprises Ltd's solvency score is 37/100. The higher the solvency score, the more solvent the company is.
Score
Healthcare Global Enterprises Ltd's solvency score is 37/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HCG Price Targets Summary
Healthcare Global Enterprises Ltd
According to Wall Street analysts, the average 1-year price target for HCG is 542.47 INR with a low forecast of 439.35 INR and a high forecast of 630 INR.
Dividends
Current shareholder yield for HCG is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
HCG Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
HealthCare Global Enterprises Ltd. provides imaging and diagnostics services for cancer treatment. The company is headquartered in Bangalore, Karnataka. The company went IPO on 2016-03-30. The firm is involved retail sale of pharmaceuticals, medical and orthopedic goods and toilet articles. The company operates cancer care network under the HCG brand. The company operates infertility treatment clinics providing assisted reproductive services under brand Milann. The firm operates eight Milann fertility centers, which provide reproductive medicine services, including assisted reproduction, gynecological endoscopy and fertility preservation; and follow a multidisciplinary and technology-focused approach to diagnosis and treatment. Milann fertility centers also offer training programs for fertility specialists and embryologists. Under the Triesta brand, it provides clinical reference laboratory services with specialization in oncology.
Contact
IPO
Employees
Officers
The intrinsic value of one HCG stock under the Base Case scenario is 492.71 INR.
Compared to the current market price of 468.3 INR, Healthcare Global Enterprises Ltd is Undervalued by 5%.